U.S. Markets closed

Novavax CFO to resign effective May 17

Novavax disclosed in a regulatory filing that on April 25, Fred Driscoll gave notice of his intention to resign as VP and CFO of Novavax effective May 17. Driscoll plans to pursue an opportunity with a Massachusetts-based specialty pharmaceutical company.